ZA968788B - 4A, 5A, 8A, 8B-tetrahydro-6H-pyrrolo(3',4':4,5)furo(3,2-B)pyridine-6,8(7H)-dione derivatives for control of endoparasites processes for their preparation - Google Patents

4A, 5A, 8A, 8B-tetrahydro-6H-pyrrolo(3',4':4,5)furo(3,2-B)pyridine-6,8(7H)-dione derivatives for control of endoparasites processes for their preparation

Info

Publication number
ZA968788B
ZA968788B ZA968788A ZA968788A ZA968788B ZA 968788 B ZA968788 B ZA 968788B ZA 968788 A ZA968788 A ZA 968788A ZA 968788 A ZA968788 A ZA 968788A ZA 968788 B ZA968788 B ZA 968788B
Authority
ZA
South Africa
Prior art keywords
endoparasites
furo
pyrrolo
tetrahydro
pyridine
Prior art date
Application number
ZA968788A
Other languages
English (en)
Inventor
Peter Jeschke
Achim Harder
Norbert Mencke
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA968788B publication Critical patent/ZA968788B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA968788A 1995-10-19 1996-10-18 4A, 5A, 8A, 8B-tetrahydro-6H-pyrrolo(3',4':4,5)furo(3,2-B)pyridine-6,8(7H)-dione derivatives for control of endoparasites processes for their preparation ZA968788B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19538960A DE19538960A1 (de) 1995-10-19 1995-10-19 4a,5a,8a,8b-Tetrahydro-6H-pyrrolo [3',4':4,5] furo [3,2-b] pyridin-6,8(7H)-dion Derivate zur Bekämpfung von Endoparasiten, Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ZA968788B true ZA968788B (en) 1996-12-03

Family

ID=7775277

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA968788A ZA968788B (en) 1995-10-19 1996-10-18 4A, 5A, 8A, 8B-tetrahydro-6H-pyrrolo(3',4':4,5)furo(3,2-B)pyridine-6,8(7H)-dione derivatives for control of endoparasites processes for their preparation

Country Status (24)

Country Link
US (2) US6110928A (es)
EP (1) EP0871630B1 (es)
JP (1) JP4157163B2 (es)
KR (1) KR100444144B1 (es)
CN (1) CN1111535C (es)
AR (1) AR004023A1 (es)
AT (1) ATE211475T1 (es)
AU (1) AU706836B2 (es)
BR (1) BR9611002B1 (es)
CZ (1) CZ295075B6 (es)
DE (2) DE19538960A1 (es)
DK (1) DK0871630T3 (es)
ES (1) ES2170271T3 (es)
HK (1) HK1017359A1 (es)
HU (1) HUP9802854A3 (es)
NO (1) NO323609B1 (es)
NZ (1) NZ320174A (es)
PL (1) PL185960B1 (es)
PT (1) PT871630E (es)
SK (1) SK284914B6 (es)
TR (1) TR199800686T2 (es)
TW (1) TW466241B (es)
WO (1) WO1997014695A1 (es)
ZA (1) ZA968788B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19719839A1 (de) * 1997-05-12 1998-11-19 Bayer Ag 6-Substituierte 1,2,4a,5a,8a,8b-Hexahydro- und 1,2,3,4,4a,5a,8a,8b-Oktahydro-6H-pyrrolo/3',4':4,5/furo/3,2-b/pyrid-8(7H)-on Derivate und ihre Verwendung zur Bekämpfung von Endoparasiten
DE10201544A1 (de) * 2002-01-17 2003-07-31 Bayer Cropscience Ag Substituierte Pyrazoline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4032090A1 (de) * 1990-02-13 1991-08-14 Bayer Ag Polycyclische 3-aryl-pyrrolidin-2,4-dion-derivate
DE4121365A1 (de) * 1991-06-28 1993-01-14 Bayer Ag Substituierte 1-h-3-aryl-pyrrolidin-2,4-dion-derivate

Also Published As

Publication number Publication date
AU7286596A (en) 1997-05-07
PT871630E (pt) 2002-06-28
CN1204335A (zh) 1999-01-06
PL326323A1 (en) 1998-09-14
SK284914B6 (sk) 2006-02-02
CZ295075B6 (cs) 2005-05-18
HUP9802854A2 (hu) 1999-05-28
CZ118898A3 (cs) 1998-08-12
DK0871630T3 (da) 2002-04-29
EP0871630A1 (de) 1998-10-21
NO981502L (no) 1998-04-02
DE19538960A1 (de) 1997-04-24
TW466241B (en) 2001-12-01
BR9611002A (pt) 1999-07-13
CN1111535C (zh) 2003-06-18
JP4157163B2 (ja) 2008-09-24
KR19990063812A (ko) 1999-07-26
KR100444144B1 (ko) 2005-01-13
TR199800686T2 (xx) 1998-07-21
DE59608617D1 (de) 2002-02-28
ES2170271T3 (es) 2002-08-01
EP0871630B1 (de) 2002-01-02
BR9611002B1 (pt) 2010-11-30
JPH11513675A (ja) 1999-11-24
NZ320174A (en) 2000-12-22
NO323609B1 (no) 2007-06-18
WO1997014695A1 (de) 1997-04-24
AR004023A1 (es) 1998-09-30
US6110928A (en) 2000-08-29
AU706836B2 (en) 1999-06-24
PL185960B1 (pl) 2003-09-30
HK1017359A1 (en) 1999-11-19
HUP9802854A3 (en) 2001-12-28
US6291472B1 (en) 2001-09-18
NO981502D0 (no) 1998-04-02
ATE211475T1 (de) 2002-01-15
SK49298A3 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
HK1013988A1 (en) Crystal forms of a thieno(2,3-b)(1,5) benzodiazepine derivative and process for their preparation
HK1046274B (zh) 用於治療精神和智力損害疾病的螺[1-氮雜雙環[2‧2‧2]辛烷-3，2'(3'h)-呋喃並[2，3-b]吡啶
HUP9700885A3 (en) Novel process for producing thieno[3,2-c]pyridine derivatives
HUP9702219A3 (en) 6-[4-(acylamino)benzoyl]-pyrazolo[3,4-d]thieno[3,2-b]azepine derivatives, process for their preparation and pharmaceutical compositions containing them
FI92828C (fi) Menetelmä valmistaa terapeuttisesti arvokasta 5,11-dihydro-6H-dipyrido/3,2-b:2',3'-e/ /1,4/diatsepin-6-onia
AU3611093A (en) Substituted furo(3',4':6,7)indolizino(1,2-b)quinolinones
DK0733634T3 (da) Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat
IL90389A (en) (1-substituted-1,4-dihydro- (1)benzo (thio) pyrano (4,3-c)pyrazol-3-yl) -3-oxopropanenitrile derivatives, their preparation and pharmaceutical compositions containing them
ZA968788B (en) 4A, 5A, 8A, 8B-tetrahydro-6H-pyrrolo(3',4':4,5)furo(3,2-B)pyridine-6,8(7H)-dione derivatives for control of endoparasites processes for their preparation
HUP9602054A2 (en) Benzofuro- and benzothieno[3,2-b]pyridine derivatives, pharmaceutical compositions containing them, and process for the preparation thereof
HUP0300569A3 (en) Pyrano[2,3-c]imidazo[-1,2-a]pyridine derivatives for the treatment of gastrointestinal disorders and pharmaceutical compositions containing the compounds
DK0880522T3 (da) 5H,10H-Imidazo[1,2-a]indeno[1,2-e]pyrazin-4-on-derivater AMPA- og NMDA-receptorantagonister, deres fremstilling, deres mellemprodukter og lægemidler med indhold deraf
WO2003037903A8 (en) Olanzapine dihydrate-ii a process for its preparation and use thereof
PL324928A1 (en) Derivatives of pyrimidin-4-one, their application, intermediate compounds for their production and methods of obtaining such intermediate compounds
HUP0002380A3 (en) 6-substituted 1,2,4a,5a,8a,8b-hexahydro- and 1,2,3,4,4a,5a,8a,8b-octahydro-6h-pyrrolo-[3',4':4,5]furo[3,2-b]pyrid-8(7h)-on derivatives, their use, pharmaceutical compositions containing them and process for their preparation
HRP960199B1 (en) SYNTHESIS OF AN INTERMEDIATE FOR THE PREPARATION OF 5,6-DIHYDRO-(S)-4-(ETHYLAMINO)-(S)-6-METHYL-4H-THIENO(2,3-b)THIOPYRAN-2-SULFONAMIDE 7,7-DIOXIDE INTERMEDIATES AND RELATED COMPOUNDS
ZA918335B (en) Method for the preparation of 5,11-dihydro-6h-dipyrido(3,2-b:2',3'-e)(1,4)diazepines
HUP9902086A3 (en) Thieno[2,3-b]pyrazolo[3,4-d]pyridin-3-ones, their use, pharmaceutical compositions containing them, process for their preparation, intermediates
CA2235017A1 (en) 4a,5a,8a,8b-tetrahydro-6h-pyrrolo[3,4':4,5]furo(3,2-b)pyridine-6,8[7h]-dione derivatives for use in controlling endoparasites and a method of producing said derivatives
PL327412A1 (en) Novel derivatives of spiro[2-h-1-benzopyrane-2,4'-piperidin]-4(3h)-none
ZA955942B (en) 4-hydroxy-3-phenylindeno[1,2-b]pyridin-2(1H)-one derivatives their preparation and the medicaments containing them
AU646096C (en) Method for the preparation of 5,11-dihydro-6H-dipyrido (3,2-b:2',3'-e)(1,4)diazepines
HUT64543A (en) Process for production of spiro (piperidine-4,1' /1h/pyrido [3,4-b]indole)-derivatives and of pharmaceutical compositions containing it
PL326179A1 (en) Derivatives of 2,3-dihydrofuro(2,3-b)pyridine, 3,4-dihydro-2h-pyrane(2,3-b)pyridine and benzo(b)furo(2,3-b)pyrazine
HUP9901946A3 (en) 5,10-dihydropyrido[2,3-b:2,3-e]pirazin- and 5,10-dihydropyrido[2,3-b:3,2-e]-pyrazin derivatives, process for producing them, pharmaceutical compositions containing them and intermediates